| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/26/1995 | EP0649901A1 Human cell lines with Langerhans cell properties |
| 04/26/1995 | EP0649853A1 Modified glass fiber membranes useful for DNA purification by solid phase extraction |
| 04/26/1995 | EP0649852A1 Fractionation method for nucleotide fragments |
| 04/26/1995 | EP0649537A1 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes |
| 04/26/1995 | EP0649472A1 Fusion proteins comprising eukaryotic cytochrome p450 fused to a reductase |
| 04/26/1995 | EP0649471A1 Recombinant cellulases |
| 04/26/1995 | EP0649470A1 Immediate early hsv-2 viral protein icp27 as vaccine |
| 04/26/1995 | EP0649469A1 Gene activating element |
| 04/26/1995 | EP0649468A1 Soluble cr1 derivatives |
| 04/26/1995 | EP0649467A1 Self-stabilized oligonucleotides as therapeutic agents |
| 04/26/1995 | EP0649466A1 Method of inhibiting viral replication |
| 04/26/1995 | EP0649435A1 Membrane-associated immunogens of mycobacteria |
| 04/26/1995 | EP0649429A1 Heteroatomic oligonucleoside linkages |
| 04/26/1995 | EP0649428A1 Process and device for preparing dna sodium salt |
| 04/26/1995 | EP0590086A4 Novel organ-specific plant promoter sequences. |
| 04/26/1995 | EP0580782A4 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 04/26/1995 | EP0564595B1 Stable transformation of monocot plant cells by electoporation |
| 04/26/1995 | EP0552276A4 Detergent compositions containing cellulase compositions enriched in acidic endoglucanase type components |
| 04/26/1995 | EP0544746B1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 04/26/1995 | EP0515484B1 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 04/26/1995 | EP0455707B1 BLOOD-COAGULATION FACTOR BETAXIIa MONOCLONAL ANTIBODY AND IMMUNOASSAY |
| 04/26/1995 | EP0438587B1 Nucleic acid probes for the detection of pneumocystis carinii |
| 04/26/1995 | EP0423302B1 Application of novel dna fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeasts and corresponding process for the preparation of proteins |
| 04/26/1995 | EP0419513B1 Recombinant flagellin vaccines |
| 04/26/1995 | EP0381706B1 A method of maintaining a desired recombinant gene in a genetic population of cells |
| 04/26/1995 | EP0366668B1 Novel bacillus thuringiensis strains, method for their isolation and related insecticidal compositions |
| 04/26/1995 | EP0357611B1 A method of detection of carcinogenic human papillomavirus |
| 04/26/1995 | EP0216846B2 Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| 04/26/1995 | CN1101945A Secretion expression of precursor gene of insulin in yeast and preparing process for human insulin |
| 04/25/1995 | US5410096 Plants with modified flower color and methods for their production by genetic engineering |
| 04/25/1995 | US5410026 Method for refolding insoluble, misfolded insulin-like growth factor-1 into an active conformation |
| 04/25/1995 | US5410018 Bombesin-related peptides |
| 04/25/1995 | US5409897 Cysteine-modified acidic fibroblast growth factor and methods of use |
| 04/25/1995 | US5409895 Protease inhibitory polypeptides derived from urinary trypsin inhibitor and compositions thereof |
| 04/25/1995 | US5409837 Modified unF-13 protein and gene |
| 04/25/1995 | US5409824 γ-CGTase |
| 04/25/1995 | US5409823 Methods for the production of hybrid seed |
| 04/25/1995 | US5409815 DNA's encoding signal peptides |
| 04/25/1995 | US5409810 Nucelic acid derivatives |
| 04/25/1995 | US5409700 Pharmaceutical compositions comprising modified and unmodified plasminogen activators |
| 04/25/1995 | CA1335360C Recombinant natural killer cell activator |
| 04/25/1995 | CA1335359C Dna encoding human monoamine oxides type a |
| 04/25/1995 | CA1335358C Cks method of protein synthesis |
| 04/25/1995 | CA1335357C Expression systems for preparation of polypeptides in prokaryotic cells |
| 04/25/1995 | CA1335355C Anti-cpbii monoclonal antibody |
| 04/25/1995 | CA1335354C Anti-pci monoclonal antibody |
| 04/25/1995 | CA1335353C Monoclonal antibody for colorectal carcinoma |
| 04/23/1995 | CA2118457A1 Animal model for use in screening of prophylactic and therapeutic agents for ige-related diseases |
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010776A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010629A1 A detection system for mutagens that also identifies mutagenic changes |
| 04/20/1995 | WO1995010625A1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 04/20/1995 | WO1995010624A1 Endosomolytically active particles |
| 04/20/1995 | WO1995010623A1 Selective adenoviral mediated gene transfer into vascular neointima |
| 04/20/1995 | WO1995010622A1 Modified fruit containing galactanase transgene |
| 04/20/1995 | WO1995010621A1 Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria |
| 04/20/1995 | WO1995010620A1 A plasmid vector useful for the expression of a foreign dna sequence |
| 04/20/1995 | WO1995010619A2 Methods of increasing rates of infection by directing motion of vectors |
| 04/20/1995 | WO1995010618A2 Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms |
| 04/20/1995 | WO1995010617A2 Alpha-1,4-glucan lyase from a fungus, its purification gene cloning and expression in microorganisms |
| 04/20/1995 | WO1995010616A2 USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE |
| 04/20/1995 | WO1995010615A1 Subtilisin variants |
| 04/20/1995 | WO1995010614A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | WO1995010613A1 Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carine |
| 04/20/1995 | WO1995010612A1 FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) |
| 04/20/1995 | WO1995010611A1 Method of inducing and maintaining neuronal cells |
| 04/20/1995 | WO1995010610A1 BETAGLYCAN POLYPEPTIDES HAVING TGF-β BINDING ACTIVITY |
| 04/20/1995 | WO1995010609A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 04/20/1995 | WO1995010608A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 04/20/1995 | WO1995010607A1 Antisense oligonucleotide generators |
| 04/20/1995 | WO1995010606A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | WO1995010603A1 Amylase variants |
| 04/20/1995 | WO1995010602A1 H2o2-stable peroxidase variants |
| 04/20/1995 | WO1995010592A1 Bleaching compositions comprising protease enzymes |
| 04/20/1995 | WO1995010591A1 Protease-containing cleaning compositions |
| 04/20/1995 | WO1995010540A1 Fas antagonists and uses thereof |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010536A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor |
| 04/20/1995 | WO1995010526A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 04/20/1995 | WO1995010300A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same |
| 04/20/1995 | WO1995010185A1 Superoxide dismutase and mimetics thereof |
| 04/20/1995 | WO1995010178A1 A method of plant tissue culture and regeneration |
| 04/20/1995 | WO1995006733A3 Glycerin-3-phosphate-dehydrogenase (gpdh) |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174132A1 Fas antagonists and uses thereof |
| 04/20/1995 | CA2174089A1 Plasmodium falciparum ribonucleotide reductase, encoding dna, and inhibitors |
| 04/20/1995 | CA2173946A1 H2o2-stable peroxidase variants |
| 04/20/1995 | CA2173751A1 Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms |
| 04/20/1995 | CA2173606A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof |
| 04/20/1995 | CA2172992A1 Methods of increasing rates of infection by directing motion of vectors |
| 04/20/1995 | CA2172271A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | CA2172139A1 Endosomolytically active particles |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2170760A1 A method of plant tissue culture and regeneration |
| 04/19/1995 | EP0648964A1 Manifold valve assembly with removable valve seat |
| 04/19/1995 | EP0648845A2 Method for coamplification of two different nucleic acid sequences using polymerase chain reaction |
| 04/19/1995 | EP0648844A2 Method of primary screening of carriers having abnormal genetic base sequences |